These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7239091)

  • 1. [Hemodynamic changes produced by intravenous bumetanide in congestive heart failure].
    Ziacchi V; Rossi A; Lomanto B
    G Ital Cardiol; 1981; 11(1):104-9. PubMed ID: 7239091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of hydralazine in the cardiac insufficiency of non-obstructive myocardiopathy].
    Pailloncy M; Fernandez F; Lelguen C; Datchary J; Ponsonnaille J; Gerbaux A; Gras H
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):276-83. PubMed ID: 114138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.
    Braunschweig F; Linde C; Eriksson MJ; Hofman-Bang C; Rydén L
    Eur Heart J; 2002 Jan; 23(1):59-69. PubMed ID: 11741363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P; Zieliński T; Korewicki J
    Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and medium term results of tailored therapy for heart failure.
    Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
    Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
    Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term hemodynamic function of the transplanted heart].
    Tatou E; Eicher JC; Charve P; Gomez MC; Jazayeri S; Fenot P; Brenot R; David M
    Arch Mal Coeur Vaiss; 2000 Jun; 93(6):703-9. PubMed ID: 10916653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic action of bumetanide in congestive heart failure.
    Olsen KH; Sigurd B; Hesse B; Steiness E; Leth A
    Postgrad Med J; 1975; 51 Suppl 6():54-63. PubMed ID: 1105534
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bumetanide in renal insufficiency].
    Humair L
    Schweiz Med Wochenschr; 1982 Feb; 112(9):310-4. PubMed ID: 7079713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immediate hemodynamic response to atrioventricular+ stimulation in severe hypertrophic obstructive myocardiopathy].
    Tascón Pérez JC; Albarrán A; Trevilla G; Alonso Gutiérrez M; Andreu Dussac J; Lombera Romero F; Escribano Subías P; Hernández Afonso J; Hernández Hernández F; Coma Samartín R; Rodríguez García J; García Cosío F
    Rev Esp Cardiol; 1996 Nov; 49(11):815-22. PubMed ID: 9082492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.